NasdaqGS:RPRXPharmaceuticals
Royalty Pharma (RPRX) Acquires US$885 Million Royalty Interest In Amgen's Imdelltra
Royalty Pharma (RPRX) recently acquired a royalty interest in Amgen's Imdelltra, a move that may have added confidence to investors, contributing to the company's 11% share price increase over the last quarter. This acquisition, along with its royalty sharing arrangements and the drug's anticipated market success, illustrates Royalty Pharma’s strategic business expansion. Concurrently, it saw enhancements in its board composition with new appointments, which might have played a beneficial...